Reaction Details Report a problem with these data
Target
Cannabinoid receptor 2
Ligand
BDBM419264
Substrate
n/a
Meas. Tech.
Radioligand Binding Assay
Ki
55.6±n/a nM
Citation
 Gobbi, L; Grether, U; Guba, W; Kretz, J; Martin, RE; Westphal, MV [1,2,3]triazolo[4,5-d]pyrimidine derivatives US Patent  US10457684 Publication Date 10/29/2019 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM419264
Synonyms:
5-tert-Butyl-3-({2-chloro-4-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}methyl)-7-(3,3-difluoropyrrolidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine | US10457684, Example 8
Type:
Small organic molecule
Emp. Form.:
C21H20ClF5N8
Mol. Mass.:
514.882
SMILES:
CC(C)(C)c1nc(N2CCC(F)(F)C2)c2nnn(Cc3ccc(cc3Cl)C3(N=N3)C(F)(F)F)c2n1 |c:29|
Structure:
Search PDB for entries with ligand similarity: